The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Global, regional, and national burden of rheumatoid arthritis, 1990–2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021
Open accessAbstract
Background: Rheumatoid arthritis is a chronic autoimmune inflammatory disease associated with disability and premature death. Up-to-date estimates of the burden of rheumatoid arthritis are required for health-care planning, resource allocation, and prevention. As part of the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021, we provide updated estimates of the prevalence of rheumatoid arthritis and its associated deaths and disability-adjusted life-years (DALYs) by age, sex, year, and location, with forecasted prevalence to 2050. Methods: Rheumatoid arthritis prevalence was estimated in 204 countries and territories from 1990 to 2020 using Bayesian meta-regression models and data from population-based studies and medical claims data (98 prevalence and 25 incidence studies). Mortality was estimated from vital registration data with the Cause of Death Ensemble model (CODEm). Years of life lost (YLL) were calculated with use of standard GBD lifetables, and years lived with disability (YLDs) were estimated from prevalence, a meta-analysed distribution of rheumatoid arthritis severity, and disability weights. DALYs were calculated by summing YLLs and YLDs. Smoking was the only risk factor analysed. Rheumatoid arthritis prevalence was forecast to 2050 by logistic regression with Socio-Demographic Index as a predictor, then multiplying by projected population estimates. Findings: In 2020, an estimated 17·6 million (95% uncertainty interval 15·8-20·3) people had rheumatoid arthritis worldwide. The age-standardised global prevalence rate was 208·8 cases (186·8-241·1) per 100 000 population, representing a 14·1% (12·7-15·4) increase since 1990. Prevalence was higher in females (age-standardised female-to-male prevalence ratio 2·45 [2·40-2·47]). The age-standardised death rate was 0·47 (0·41-0·54) per 100 000 population (38 300 global deaths [33 500-44 000]), a 23·8% (17·5-29·3) decrease from 1990 to 2020. The 2020 DALY count was 3 060 000 (2 320 000-3 860 000), with an age-standardised DALY rate of 36·4 (27·6-45·9) per 100 000 population. YLDs accounted for 76·4% (68·3-81·0) of DALYs. Smoking risk attribution for rheumatoid arthritis DALYs was 7·1% (3·6-10·3). We forecast that 31·7 million (25·8-39·0) individuals will be living with rheumatoid arthritis worldwide by 2050. Interpretation: Rheumatoid arthritis mortality has decreased globally over the past three decades. Global age-standardised prevalence rate and YLDs have increased over the same period, and the number of cases is projected to continue to increase to the year 2050. Improved access to early diagnosis and treatment of rheumatoid arthritis globally is required to reduce the future burden of the disease. Funding: Bill & Melinda Gates Foundation, Institute of Bone and Joint Research, and Global Alliance for Musculoskeletal Health.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Arnett, F. C., Edworthy, S. M., Bloch, D. A., Mcshane, D. J., Fries, J. F., Cooper, N. S., Healey, L. A., Kaplan, S. R., Liang, M. H., Luthra, H. S., et al. (1988) · Arthritis & Rheumatism · doi:10.1002/art.1780310302 · Cited by 19,752
Vos, T., Lim, S. S., Abbafati, C., Abbas, K. M., Abbasi, M., Abbasifard, M., Abbasi-Kangevari, M., Abbastabar, H., Abd-Allah, F., Abdelalim, A., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30925-9 · Cited by 19,358
Self-citationMurray, C. J. L., Aravkin, A. Y., Zheng, P., Abbafati, C., Abbas, K. M., Abbasi-Kangevari, M., Abd-Allah, F., Abdelalim, A., Abdollahi, M., Abdollahpour, I., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30752-2 · Cited by 9,854
Self-citationAletaha, D., Neogi, T., Silman, A. J., Funovits, J., Felson, D. T., Bingham, C. O., Birnbaum, N. S., Burmester, G. R., Bykerk, V. P., Cohen, M. D., et al. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27584 · Cited by 9,619
Foreman, K. J., Marquez, N., Dolgert, A., Fukutaki, K., Fullman, N., McGaughey, M., Pletcher, M. A., Smith, A. E., Tang, K., Yuan, C.-W., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31694-5 · Cited by 2,994
Self-citation2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis
Singh, J. A., Saag, K. G., Bridges, S. L., Akl, E. A., Bannuru, R. R., Sullivan, M. C., Vaysbrot, E., McNaughton, C., Osani, M., Shmerling, R. H., et al. (2016) · Arthritis & Rheumatology · doi:10.1002/art.39480 · Cited by 2,777
Self-citationSmolen, J. S., Landewé, R. B. M., Bijlsma, J. W. J., Burmester, G. R., Dougados, M., Kerschbaumer, A., McInnes, I. B., Sepriano, A., van Vollenhoven, R. F., de Wit, M., et al. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2019-216655 · Cited by 2,710
Smolen, J. S., Landewé, R., Bijlsma, J., Burmester, G., Chatzidionysiou, K., Dougados, M., Nam, J., Ramiro, S., Voshaar, M., van Vollenhoven, R., et al. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-210715 · Cited by 2,057
Guidelines for accurate and transparent health estimates reporting: the GATHER statement
Stevens, G. A., Alkema, L., Black, R. E., Boerma, J. T., Collins, G. S., Ezzati, M., Grove, J. T., Hogan, D. R., Hogan, M. C., Horton, R., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30388-9 · Cited by 1,798
Self-citationSafiri, S., Kolahi, A.-A., Smith, E., Hill, C., Bettampadi, D., Mansournia, M. A., Hoy, D., Ashrafi-Asgarabad, A., Sepidarkish, M., Almasi-Hashiani, A., et al. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2019-216515 · Cited by 1,651
Self-citation
Cited by
Gan, D., Qin, L., & Xiao, G. (2026) · Research · doi:10.34133/research.1319 · Cited by 1
Metadata
- Authors
- Black, R. J., Cross, M., Haile, L. M., Culbreth, G. T., Steinmetz, J. D., Hagins, H., Kopec, J. A., Brooks, P. M., Woolf, A. D., Ong, K. L., Kopansky-Giles, D. R., Dreinhoefer, K. E., Betteridge, N., Aali, A., Abbasifard, M., Abbasi-Kangevari, M., Abdurehman, A. M., Abedi, A., Abidi, H., Aboagye, R. G., Abolhassani, H., Abu-Gharbieh, E., Abu-Zaid, A., Adamu, K., Addo, I. Y., Adesina, M. A., Adnani, Q. E. S., Afzal, M. S., Ahmed, A., Aithala, J. P., Akhlaghdoust, M., Alemayehu, A., Alvand, S., Alvis-Zakzuk, N. J., Amu, H., Antony, B., Arabloo, J., Aravkin, A. Y., Arulappan, J., Ashraf, T., Athari, S. S., Azadnajafabad, S., Badawi, A., Baghcheghi, N., Baig, A. A., Balta, A. B., Banach, M., Banik, P. C., Barrow, A., Bashiri, A., Bearne, L. M., Bekele, A., Bensenor, I. M., Berhie, A. Y., Bhagavathula, A. S., Bhardwaj, P., Bhat, A. N., Bhojaraja, V. S., Bitaraf, S., Bodicha, B. B. A., Botelho, J. S., Briggs, A. M., Buchbinder, R., Castañeda-Orjuela, C. A., Charalampous, P., Chattu, V. K., Coberly, K., Cruz-Martins, N., Dadras, O., Dai, X., de Luca, K., Dessalegn, F. N., Dessie, G., Dhimal, M., Digesa, L. E., Diress, M., Doku, P. N., Edinur, H. A., Ekholuenetale, M., Elhadi, M., El-Sherbiny, Y. M., Etaee, F., Ezzeddini, R., Faghani, S., Filip, I., Fischer, F., Fukumoto, T., Ganesan, B., Gebremichael, M. A., Gerema, U., Getachew, M. E., Ghashghaee, A., Gill, T. K., Gupta, B., Gupta, S., Gupta, V. B., Gupta, V. K., Halwani, R., Hannan, M. A., Haque, S., Harlianto, N. I., Harorani, M., Hasaballah, A. I., Hassen, M. B., Hay, S. I., Hayat, K., Heidari, G., Hezam, K., Hill, C. L., Hiraike, Y., Horita, N., Hoveidaei, A. H., Hsiao, A. K., Hsieh, E., Hussain, S., Iavicoli, I., Ilic, I. M., Islam, S. M. S., Ismail, N. E., Iwagami, M., Jakovljevic, M., Jani, C. T., Jeganathan, J., Joseph, N., Kadashetti, V., Kandel, H., Kanko, T. K., Karaye, I. M., Khajuria, H., Khan, M. J., Khan, M. A., Khanali, J., Khatatbeh, M. M., Khubchandani, J., Kim, Y. J., Kisa, A., Kolahi, A.-A., Kompani, F., Koohestani, H. R., Koyanagi, A., Krishan, K., Kuddus, M., Kumar, N., Kuttikkattu, A., Larijani, B., Lim, S. S., Lo, J., Machado, V. S., Mahajan, P. B., Majeed, A., Malakan Rad, E., Malik, A. A., Mansournia, M. A., Mathews, E., Mendes, J. J., Mentis, A.-F. A., Mesregah, M. K., Mestrovic, T., Mirghaderi, S. P., Mirrakhimov, E. M., Misganaw, A., Mohamadkhani, A., Mohammed, S., Mokdad, A. H., Moniruzzaman, M., Montasir, A. A., Mulu, G. B., Murillo-Zamora, E., Murray, C. J. L., Mustafa, G., Naghavi, M., Nair, T. S., Naqvi, A. A., Natto, Z. S., Nayak, B. P., Neupane, S., Nguyen, C. T., Niazi, R. K., Nzoputam, O. J., Oh, I.-H., Okati-Aliabad, H., Okonji, O. C., Olufadewa, I. I., Owolabi, M. O., Pacheco-Barrios, K., Padubidri, J. R., Patel, J., Pathan, A. R., Pawar, S., Pedersini, P., Perianayagam, A., Petcu, I.-R., Qattea, I., Radfar, A., Rafiei, A., Rahman, M. H. U., Rahmanian, V., Rashedi, V., Rashidi, M.-M., Ratan, Z. A., Rawaf, S., Razeghinia, M. S., Redwan, E. M. M., Renzaho, A. M. N., Rezaei, N., Rezaei, N., Riad, A., Saad, A. M. A., Saddik, B., Saeed, U., Safary, A., Sahebazzamani, M., Sahebkar, A., Sahoo, H., Salek Farrokhi, A., Saqib, M. A. N., Seylani, A., Shahabi, S., Shaikh, M. A., Shashamo, B. B., Shetty, A., Shetty, J. K., Shigematsu, M., Shivarov, V., Shobeiri, P., Sibhat, M. M., Sinaei, E., Singh, A., Singh, J. A., Singh, P., Singh, S., Siraj, M. S., Skryabina, A. A., Slater, H., Smith, A. E., Solomon, Y., Soltani-Zangbar, M. S., Tabish, M., Tan, K.-K., Tat, N. Y., Tehrani-Banihashemi, A., Tharwat, S., Tovani-Palone, M. R., Tusa, B. S., Valadan Tahbaz, S., Valdez, P. R., Valizadeh, R., Vaziri, S., Vollset, S. E., Wu, A.-M., Yada, D. Y., Yehualashet, S. S., Yonemoto, N., You, Y., Yunusa, I., Zangiabadian, M., Zare, I., Zarrintan, A., Zhang, Z.-J., Zhong, C., Zoladl, M., Vos, T., & March, L. M.
- Venue
- The Lancet Rheumatology
- Publisher
- Elsevier BV
- Published
- 2023-10
- Volume
- 5
- Issue
- 10
- Pages
- e594-e610
- ISSN
- 2665-9913 (ISSN-L)
- OpenAlex
- W4387030217
- Cited by
- 674
- References
- 35
- FWCI
- 116.68
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Global, regional, and national burden of rheumatoid arthritis, 1990–2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021. https://app.cochat.ai/papers/10.1016/s2665-9913(23)00211-4
- The paper
- Black, R. J., Cross, M., Haile, L. M., Culbreth, G. T., Steinmetz, J. D., Hagins, H., Kopec, J. A., Brooks, P. M., Woolf, A. D., Ong, K. L., Kopansky-Giles, D. R., Dreinhoefer, K. E., Betteridge, N., Aali, A., Abbasifard, M., Abbasi-Kangevari, M., Abdurehman, A. M., Abedi, A., Abidi, H., . . . March, L. M. (2023). Global, regional, and national burden of rheumatoid arthritis, 1990–2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021. The Lancet Rheumatology. https://doi.org/10.1016/s2665-9913(23)00211-4
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.